Cited by 74Bone Metabolism and DiseasesThyroid Disorders and TreatmentsBone health and osteoporosis research

Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL–RANK interaction

Kanatani, Masanori, Sugimoto, Toshitsugu, Sowa, Hideaki, Kobayashi, Tatsuya, Kanzawa, Michiko, Chihara, Kazuo·2004·Journal of Cellular Physiology

Abstract

It is well known that thyroid hormone excess causes bone loss. However, the precise mechanism of bone loss by thyroid hormone still remains unclear. When T 3 was added to unfractionated bone cells after degeneration of pre‐existent osteoclasts, T 3(1 pM–100 nM) dose‐dependently stimulated osteoclast‐like cell formation, irrespective of the presence of indomethacin and IL‐6 Ab. T 3 increased the expression of osteoprotegerin (OPG) messenger RNA (mRNA), but not of receptor activator of nuclear factor κB ligand (RANKL) in unfractionated bone cells, suggesting that the stimulatory effect of T 3 on osteoclast formation was not mediated by the RANKL/OPG system. We next examined the direct effect of T 3 on osteoclast precursors in the absence of osteoblasts, using hemopoietic blast cells derived from spleen cells. T 3(1 pM–100 nM) dose‐dependently stimulated osteoclast‐like cell formation from osteoclast precursors. OPG did not inhibit T 3‐induced osteoclast formation from osteoclast precursor cells. The polymerase chain reaction (PCR) product corresponding in size to the mouse T 3 receptor α1 cDNA was detected in osteoclast precursors from mouse hemopoietic blast cells as well as mouse heart and mouse osteoblastic cell line MC3T3‐E1 cells, suggesting that T 3 directly stimulated osteoclast‐like cell formation from osteoclast precursors in the absence of osteoblasts. Further, T 3 increased the expression of c‐Fos mRNA at 15 min and 24 h and Fra‐1 mRNA at 2 and 6 h in osteoclast precursors. Consistent with the increased expression of c‐Fos mRNA observed by RT‐PCR, the activation of c‐Fos occurred in osteoclast precursor cells stimulated by T 3, while the activation of neither NF‐κB nor MAPKs was observed by immunoblot analysis. Antisense oligodeoxynucleotides (as‐ODN) complementary to c‐Fos mRNA at 1 μM significantly inhibited T 3‐induced osteoclast‐like cell formation from osteoclast precursors in the absence of stromal cells while sense‐ODN did not affect T 3‐induced osteoclast‐like cell formation. These results indicate that T 3 directly stimulates osteoclast differentiation at least in part by up‐regulation of c‐fos protein in osteoclast precursor cells. J. Cell. Physiol. 201: 17–25, 2004. © 2004 Wiley‐Liss, Inc.

Integrity signals

Registry

Crossref · 10.1002/jcp.20041

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kanatani, M., Sugimoto, T., Sowa, H., Kobayashi, T., Kanzawa, M., & Chihara, K.
Affiliations
Kobe University (JP)
Corresponding author
Sugimoto, Toshitsugu
Venue
Journal of Cellular Physiology
Publisher
Wiley
Published
2004-02-09
Volume
201
Issue
1
Pages
17-25
ISSN
  • 0021-9541 (ISSN-L)
  • 1097-4652
OpenAlex
W2086286088
Cited by
74
References
1
Citations by year
2026: 5 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 7 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 5 · 2013: 3 · 2012: 5
FWCI
1.18
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Cellular Physiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
thyroid hormones, triiodothyronine, osteoclastogenesis, osteoclast precursors, c-fos, Fra-1, osteoprotegerin, bone loss, osteoclast-like cell formation, mitogen-activated protein kinase
MeSH terms
Animals, Carrier Proteins, Cell Differentiation, Glycoproteins, Hematopoietic Stem Cells, Membrane Glycoproteins, Mice, Inbred Strains, Osteoclasts, Receptors, Thyroid Hormone, RNA, Messenger, Spleen, Triiodothyronine, NF-kappa B, Proto-Oncogene Proteins c-fos, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Mice, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review